NIH-funded cancer study
This article was originally published in The Tan Sheet
Executive Summary
The National Institutes of Health awards Omaha, Neb.-based Creighton University $4 million to continue a "landmark" study linking vitamin D to reduced cancer risk. The original study, headed by Joan Lappe and reported in June 2007, showed for the first time in a clinical setting that postmenopausal women consuming calcium and vitamin D3 supplements at nearly three times the recommended levels could reduce the risk of cancer by 60-77 percent, the university says Jan. 26. "We must now confirm these findings with a clinical trial specifically designed to look at calcium, vitamin D and cancer," Lappe says. "Confirmation is necessary in order to have evidence solid enough to change public policy regarding intake levels for vitamin D." The four-year study begins in April and will follow 2,300 healthy, postmenopausal women from Nebraska
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.